Patterns and risk factors for noncompliance with HMG-CoA inhibitors in a managed care population

被引：0
|
作者：
Yu, AP [1 ]
Nichol, MB [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1046/j.1524-4733.2003.00631.x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [31] HMG-CoA reductase inhibitors in osteoporosis - Do they reduce the risk of fracture?
    Schlienger, RG
    Meier, CR
    DRUGS & AGING, 2003, 20 (05) : 321 - 336
  • [32] HMG-CoA reductase inhibitors reduce stroke risk, total mortality
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (19) : 2152 - &
  • [33] HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
    Wang, PS
    Solomon, DH
    Mogun, H
    Avorn, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24): : 3211 - 3216
  • [34] COMPARISON OF DIFFERENT HMG-COA REDUCTASE INHIBITORS
    DITSCHUNEIT, HH
    KUHN, K
    DITSCHUNEIT, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S27 - S32
  • [35] TISSUE SELECTIVITY OF HMG-COA REDUCTASE INHIBITORS
    SLISKOVIC, DR
    BLANKLEY, CJ
    BOCAN, TMA
    CHURCHOLOWSKI, AW
    CREGER, PL
    CRESWELL, MW
    FERGUSON, E
    OBRIEN, P
    PICARD, JA
    ROARK, WH
    ROTH, BD
    WILSON, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 124 - MEDI
  • [36] HMG-COA REDUCTASE INHIBITORS FOR HYPERCHOLESTEROLEMIA - REPLY
    GRUNDY, SM
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (18): : 1223 - 1223
  • [37] LOVASTATIN AND OTHER HMG-COA REDUCTASE INHIBITORS
    FRISHMAN, WH
    ZIMETBAUM, P
    NADELMANN, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (11): : 975 - 982
  • [38] HMG-CoA reductase inhibitors in organ transplantation
    Motomura, N
    Saito, S
    Foegh, ML
    JOURNAL OF NEPHROLOGY, 1997, 10 (02) : 68 - 76
  • [39] HMG-CoA reductase inhibitors and renal function
    Campese, Vito M.
    Park, Jeanie
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06): : 1100 - 1103
  • [40] Are HMG-CoA reductase inhibitors cost effective?
    Drugs & Therapy Perspectives, 1997, 9 (9) : 14 - 16
12345